Myocardial ischaemia adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 11,216 adverse event reports that record the MedDRA preferred term Myocardial ischaemia. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 317 reports in the 12 months to June 2026 and 261 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 115 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Myocardial ischaemia name as a suspect product, in order of name
Drug	Class	Reports with this term
Acetaminophen		62
Acetylsalicylic Acid		56
Alprazolam	Benzodiazepine	60
Amiodarone		26
Amitriptyline		26
Amlodipine	Calcium channel blocker	60
Androgel		30
Apixaban	Factor Xa inhibitor	40
Aspirin	Nonsteroidal anti-inflammatory drug	183
Atorvastatin		91
Atorvastatin calcium	HMG-CoA reductase inhibitor	34
Avandamet		378
Avandaryl		72
Avandia		2,116
Avastin	Vascular endothelial growth factor inhibitor	44
Bevacizumab	Vascular endothelial growth factor inhibitor	107
Bextra		31
Bisoprolol	beta-Adrenergic blocker	107
Brilinta	P2Y12 platelet inhibitor	38
Brilique		27
Capecitabine	Nucleoside metabolic inhibitor	109
Carboplatin	Platinum-based drug	89
Carvedilol	alpha-Adrenergic blocker	39
Cefuroxime	Cephalosporin antibacterial	31
Celebrex	Nonsteroidal anti-inflammatory drug	50
Cetuximab	Epidermal growth factor receptor antagonist	26
Cisplatin	Platinum-based drug	67
Citalopram	Serotonin reuptake inhibitor	51
Clarithromycin	Macrolide antimicrobial	53
Clopidogrel	P2Y12 platelet inhibitor	93
Clozapine	Atypical antipsychotic	50
Clozaril	Atypical antipsychotic	141
Cocaine		28
Crestor	HMG-CoA reductase inhibitor	41
Cyclophosphamide	Alkylating drug	113
Dexamethasone	Corticosteroid	110
Dextrose		25
Diazepam	Benzodiazepine	30
Digoxin	Cardiac glycoside	170
Diovan	Angiotensin 2 receptor blocker	41
Docetaxel	Microtubule inhibitor	45
Doxorubicin	Anthracycline topoisomerase inhibitor	45
Doxorubicin hydrochloride	Anthracycline topoisomerase inhibitor	40
Doxycycline	Tetracycline-class drug	25
Eliquis	Factor Xa inhibitor	34
Enbrel	Tumor necrosis factor blocker	32
Entresto	Angiotensin 2 receptor blocker	91
Epinephrine	Catecholamine	82
Etanercept	Tumor necrosis factor blocker	40
Etoposide	Topoisomerase inhibitor	45
Ezetimibe	Dietary cholesterol absorption inhibitor	29
Fentanyl	Opioid agonist	75
Fentanyl citrate	Opioid agonist	34
Fluorouracil	Nucleoside metabolic inhibitor	161
Fosamax	Bisphosphonate	81
Furosemide	Loop diuretic	56
Gabapentin	Anti-epileptic agent	46
Gemcitabine	Nucleoside metabolic inhibitor	29
Gilenya	Sphingosine 1-phosphate receptor modulator	25
Herceptin	HER2/neu receptor antagonist	29
Humira		243
Ibuprofen	Nonsteroidal anti-inflammatory drug	46
Imatinib	Kinase inhibitor	46
Imbruvica	Kinase inhibitor	28
Keytruda	Programmed death Receptor-1 blocking antibody	31
Lansoprazole	Proton pump inhibitor	33
Leucovorin calcium	Folate analog	32
Lisinopril	Angiotensin converting enzyme inhibitor	57
Lorazepam	Benzodiazepine	30
Lucentis	Vascular endothelial growth factor inhibitor	56
Metformin	Biguanide	98
Metformin hydrochloride	Biguanide	37
Methotrexate	Folate analog metabolic inhibitor	45
Methylprednisolone	Corticosteroid	27
Metoclopramide	Dopamine-2 receptor antagonist	25
Mycophenolate mofetil	Antimetabolite immunosuppressant	33
Nebivolol	beta-Adrenergic blocker	27
Nilotinib	Kinase inhibitor	62
Nitroglycerin	Nitrate vasodilator	58
Olanzapine	Atypical antipsychotic	52
Omeprazole	Proton pump inhibitor	72
Ondansetron	Serotonin-3 receptor antagonist	26
Oxaliplatin	Platinum-based drug	122
Oxycodone	Opioid agonist	34
Paclitaxel	Microtubule inhibitor	85
Pantoprazole	Proton pump inhibitor	80
Perindopril		40
Plavix	P2Y12 platelet inhibitor	45
Pradaxa	Direct thrombin inhibitor	32
Prednisolone	Corticosteroid	63
Prednisone	Corticosteroid	114
Propofol	General anesthetic	29
Propranolol	beta-Adrenergic blocker	25
Quetiapine	Atypical antipsychotic	61
Ranitidine	Histamine-2 receptor antagonist	28
Remicade	Tumor necrosis factor blocker	71
Reteplase		25
Revlimid	Thalidomide analog	58
Rituximab	CD20-directed cytolytic antibody	127
Rosiglitazone		40
Rosiglitazone maleate		45
Rosuvastatin	HMG-CoA reductase inhibitor	73
Simvastatin	HMG-CoA reductase inhibitor	63
Tacrolimus	Calcineurin inhibitor immunosuppressant	78
Tasigna	Kinase inhibitor	121
Tiotropium bromide	Anticholinergic	26
Trastuzumab	HER2/neu receptor antagonist	34
Valsartan	Angiotensin 2 receptor blocker	36
Velcade	Proteasome inhibitor	33
Venetoclax	BCL-2 inhibitor	26
Vincristine		38
Vioxx		548
Xarelto	Factor Xa inhibitor	57
Zometa		34
Zyprexa	Atypical antipsychotic	97

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 43 pharmacologic classes with 50 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Myocardial ischaemia name, in order of name
Class	Reports with this term
Alkylating drug	126
alpha-Adrenergic blocker	61
Angiotensin 2 receptor blocker	224
Angiotensin converting enzyme inhibitor	98
Anthracycline topoisomerase inhibitor	97
Anti-epileptic agent	67
Antimetabolite immunosuppressant	52
Atypical antipsychotic	489
Benzodiazepine	169
beta-Adrenergic blocker	244
Biguanide	142
Bisphosphonate	132
Calcineurin inhibitor immunosuppressant	125
Calcium channel blocker	97
Cardiac glycoside	170
Catecholamine	112
CD20-directed cytolytic antibody	139
Cephalosporin antibacterial	58
Corticosteroid	372
Epidermal growth factor receptor antagonist	55
Factor Xa inhibitor	150
Folate analog metabolic inhibitor	78
General anesthetic	52
HER2/neu receptor antagonist	72
HMG-CoA reductase inhibitor	263
Kinase inhibitor	473
Loop diuretic	69
Macrolide antimicrobial	56
Microtubule inhibitor	134
Nitrate vasodilator	96
Nonsteroidal anti-inflammatory drug	331
Nucleoside metabolic inhibitor	392
Opioid agonist	259
P2Y12 platelet inhibitor	216
Platinum-based drug	278
Programmed death Receptor-1 blocking antibody	88
Proteasome inhibitor	96
Proton pump inhibitor	244
Serotonin reuptake inhibitor	142
Thalidomide analog	78
Topoisomerase inhibitor	55
Tumor necrosis factor blocker	183
Vascular endothelial growth factor inhibitor	237

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Myocardial ischaemia, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Myocardial ischaemia
Age	Reports	Share
Under 2	34	0.3%
2 to 11	42	0.4%
12 to 17	79	0.7%
18 to 44	951	8.5%
45 to 64	3,529	31.5%
65 to 74	1,819	16.2%
75 and over	1,555	13.9%
Age not given	3,207	28.6%

Sex of the patient in the reports that record Myocardial ischaemia
Sex	Reports	Share
Female	4,243	37.8%
Male	5,670	50.6%
Unknown or not given	1,303	11.6%

Age and sex are as the report gives them. 45.2% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Myocardial ischaemia: adverse event reports that record this term. https://reportedreactions.com/reaction/myocardial-ischaemia/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 1 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Myocardial ischaemia mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page